Korro Bio (KRRO) Preferred Stock Liabilities (2018 - 2022)

Korro Bio's Preferred Stock Liabilities history runs 4 years deep, the most recent figure standing at $57.7 million for Q4 2022.

• Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $57.7 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $57.7 million (changed 0.0% YoY) and the FY2022 annual result came in at $57.7 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities was $57.7 million for Q4 2022 at Korro Bio, roughly flat from $57.7 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $147.9 million in Q3 2019 and bottomed at $46.7 million in Q4 2018.
• A 4-year average of $77.5 million and a median of $57.7 million in 2021 frame the typical range for Preferred Stock Liabilities.
• Peak annual rise in Preferred Stock Liabilities reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
• Korro Bio's Preferred Stock Liabilities stood at $46.7 million in 2018, then soared by 216.75% to $147.9 million in 2019, then sank by 60.99% to $57.7 million in 2021, then changed by 0.0% to $57.7 million in 2022.
• Business Quant data shows KRRO's Preferred Stock Liabilities at $57.7 million in Q4 2022, $57.7 million in Q4 2021, and $147.9 million in Q3 2019.